Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine in individuals aged 16–26 years in Chongqing, China
Article in Human Vaccines & Immunotherapeutics (December 2023)
The most recent citing publications are shown below. View all 27 publications that cite this research output on Dimensions.
Article in Human Vaccines & Immunotherapeutics (December 2023)
Article in Vaccines (March 2022)
Article in BMC Women's Health (February 2022)